Heron Therapeutics (HRTX)
(Delayed Data from NSDQ)
$3.47 USD
0.00 (0.00%)
Updated May 23, 2024 04:00 PM ET
After-Market: $3.46 -0.01 (-0.29%) 7:58 PM ET
2-Buy of 5 2
D Value A Growth B Momentum B VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/12/2024
Time: -- |
6/2024 | $-0.04 | 0.00% |
Earnings Summary
For their last quarter, Heron Therapeutics (HRTX) reported earnings of -$0.02 per share, beating the Zacks Consensus Estimate of $-0.08 per share. This reflects a positive earnings surprise of 75.00%. Look out for HRTX's next earnings release expected on August 12, 2024. For the next earning release, we expect the company to report earnings of -$0.04 per share, reflecting a year-over-year increase of 88.57%.
Earnings History
Price & Consensus
Zacks News for HRTX
What Makes Heron Therapeutics (HRTX) a Strong Momentum Stock: Buy Now?
HRTX: What are Zacks experts saying now?
Zacks Private Portfolio Services